Related Experiment Videos
Sustained-release applications of montmorillonite interaction with amphetamine sulfate
Journal of Pharmaceutical Sciences
|January 1, 1977
Summary
Montmorillonite clay significantly alters amphetamine sulfate levels in urine. A specific drug-clay complex formulation mimicked prolonged-release drug delivery, showing similar bioavailability after 48 hours.
Area of Science:
- Pharmacology
- Materials Science
Background:
- Montmorillonite is a clay with potential applications in drug delivery.
- Amphetamine sulfate is a stimulant medication with a defined therapeutic range.
Purpose of the Study:
- To investigate the effect of montmorillonite on amphetamine sulfate's urinary recovery.
- To evaluate the pharmacokinetic profile of amphetamine sulfate when formulated with montmorillonite.
Main Methods:
- Urinary recovery studies were conducted.
- A 1:20 drug-montmorillonite complex was prepared and combined with pure amphetamine sulfate in a 1:1 ratio.
- Bioavailability was assessed over 48 hours.
Main Results:
- Montmorillonite significantly influenced the initial urinary therapeutic levels of amphetamine sulfate.
- The drug-montmorillonite complex formulation exhibited recovery profiles similar to prolonged-release dosage forms.
- Comparable bioavailability was observed for the 1:20 complex, pure drug, and combination formulations at 48 hours.
Conclusions:
- Montmorillonite can modify the release characteristics of amphetamine sulfate.
- Formulations involving montmorillonite show potential for achieving prolonged-release profiles.
- Further research into montmorillonite-based drug delivery systems is warranted.